These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6436111)

  • 1. [Vaccination against human brucellosis. 2 years of experience].
    Bentejac MC; Biron G; Bertrand A; Bascoul S
    Dev Biol Stand; 1984; 56():531-5. PubMed ID: 6436111
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of Brucella abortus RB51 revaccinated cows.
    Blasco JM; Moriyon I
    Comp Immunol Microbiol Infect Dis; 2005; 28(5-6):371-3; author reply 375-7. PubMed ID: 16182367
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortus strain RB51 vaccine: its advantages and risks.
    Kahler SC
    J Am Vet Med Assoc; 1998 Jul; 213(1):12, 22. PubMed ID: 9656011
    [No Abstract]   [Full Text] [Related]  

  • 5. [A safety and reactogenicity study of experimentally produced batches of the brucellosis chemical vaccine with different methods for its application].
    El'shina GA; Sumarokov AA; Anisimova TI; Dranovskaia EA; Saiapina LV; Adamova GV; Bekzatov KN; Varlamov NN; Sidorenko SV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):50-3. PubMed ID: 1759522
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent serological titres following reduced dose Brucella abortus strain 19 vaccination.
    Beckett FW; MacDiarmid SC
    Br Vet J; 1987; 143(5):477-9. PubMed ID: 3119143
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Adone R
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):43-55. PubMed ID: 16112746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: immunity.
    Alton GG; Jones LM; García-Carrillo C; Trenchi A
    Am J Vet Res; 1972 Sep; 33(9):1747-51. PubMed ID: 4626469
    [No Abstract]   [Full Text] [Related]  

  • 11. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
    Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
    Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of Brucella abortus RB51 revaccinated cows, introduced in a herd with active brucellosis, with presence of atypical humoral response.
    Leal-Hernandez M; Díaz-Aparicio E; Pérez R; Andrade LH; Arellano-Reynoso B; Alfonseca E; Suárez-Güemes F
    Comp Immunol Microbiol Infect Dis; 2005 Jan; 28(1):63-70. PubMed ID: 15563954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the safety, reactogenicity and antigenic activity of chemical and live brucellosis vaccines in a controlled epidemiological trial].
    Sumarokov AA; Karinskaia GA; Dranovskaia EA; Vershilova PA; Sharipov MK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):58-63. PubMed ID: 6424361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunization of guinea-pigs and mice with a whole-culture extract of a smooth and a rough strain of Brucella abortus.
    Keppie J; Witt K; Smith H
    Br J Exp Pathol; 1972 Oct; 53(5):518-28. PubMed ID: 4628447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venezuelan field trials of vaccines against brucellosis in swine.
    Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
    Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine.
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Fosgate GT
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):209-20. PubMed ID: 15963819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.